| __timestamp | Ligand Pharmaceuticals Incorporated | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 64538000 | 4320000 |
| Thursday, January 1, 2015 | 71914000 | 2538000 |
| Friday, January 1, 2016 | 108973000 | 3337000 |
| Sunday, January 1, 2017 | 141102000 | 4003000 |
| Monday, January 1, 2018 | 251453000 | 8386000 |
| Tuesday, January 1, 2019 | 120282000 | 4461000 |
| Wednesday, January 1, 2020 | 186419000 | 1050000 |
| Friday, January 1, 2021 | 277133000 | 2963000 |
| Saturday, January 1, 2022 | 196245000 | 1772000 |
| Sunday, January 1, 2023 | 131314000 | 314000 |
In pursuit of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, Ligand Pharmaceuticals Incorporated has demonstrated a robust revenue trajectory, with a remarkable 300% increase from 2014 to 2021, peaking in 2021. In contrast, Viridian Therapeutics, Inc. has faced challenges, with revenues fluctuating and ultimately declining by over 90% from 2014 to 2023.
Ligand's strategic partnerships and innovative drug development have fueled its growth, while Viridian's journey reflects the volatility and high stakes of the biotech sector. The data highlights the importance of strategic direction and market adaptability in achieving financial success. As we look to the future, these trends offer valuable insights into the competitive landscape of biotechnology.
Breaking Down Revenue Trends: Amgen Inc. vs Ligand Pharmaceuticals Incorporated
Who Generates More Revenue? Sanofi or Ligand Pharmaceuticals Incorporated
Biogen Inc. or Ligand Pharmaceuticals Incorporated: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Genmab A/S or Viridian Therapeutics, Inc.?
Jazz Pharmaceuticals plc and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Viridian Therapeutics, Inc.
Vericel Corporation vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Vericel Corporation and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Viridian Therapeutics, Inc.
Revenue Insights: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc. Performance Compared